| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |